Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plasmodium falciparum | 20 | 2022 | 1725 | 2.100 |
Why?
|
Malaria, Falciparum | 15 | 2022 | 1064 | 1.640 |
Why?
|
Plasmodium vivax | 4 | 2020 | 196 | 1.200 |
Why?
|
DNA, Protozoan | 6 | 2020 | 227 | 1.190 |
Why?
|
Antimalarials | 9 | 2021 | 902 | 1.100 |
Why?
|
Malaria | 7 | 2022 | 1203 | 0.950 |
Why?
|
Malaria, Vivax | 4 | 2020 | 160 | 0.830 |
Why?
|
Plasmodium ovale | 2 | 2017 | 14 | 0.720 |
Why?
|
Senegal | 10 | 2022 | 254 | 0.670 |
Why?
|
Plasmodium malariae | 1 | 2017 | 13 | 0.580 |
Why?
|
Tetrahydrofolate Dehydrogenase | 3 | 2021 | 133 | 0.500 |
Why?
|
Drug Resistance | 8 | 2021 | 1600 | 0.490 |
Why?
|
Genetics, Population | 2 | 2018 | 916 | 0.460 |
Why?
|
DNA Barcoding, Taxonomic | 5 | 2020 | 133 | 0.380 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2022 | 15387 | 0.380 |
Why?
|
Plasmodium | 3 | 2018 | 244 | 0.340 |
Why?
|
Dihydropteroate Synthase | 2 | 2020 | 27 | 0.330 |
Why?
|
Genetic Variation | 6 | 2020 | 6455 | 0.280 |
Why?
|
Genomics | 3 | 2022 | 5699 | 0.260 |
Why?
|
Genome, Protozoan | 3 | 2018 | 143 | 0.260 |
Why?
|
Pyrimethamine | 2 | 2021 | 94 | 0.230 |
Why?
|
Parasitemia | 3 | 2019 | 164 | 0.220 |
Why?
|
Genotype | 8 | 2022 | 12790 | 0.220 |
Why?
|
Zambia | 2 | 2020 | 252 | 0.220 |
Why?
|
Folic Acid Antagonists | 1 | 2021 | 76 | 0.190 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2020 | 102 | 0.180 |
Why?
|
Adaptation, Biological | 1 | 2021 | 146 | 0.180 |
Why?
|
Protozoan Proteins | 3 | 2020 | 828 | 0.160 |
Why?
|
Haiti | 1 | 2020 | 540 | 0.160 |
Why?
|
Epistasis, Genetic | 1 | 2021 | 349 | 0.160 |
Why?
|
Artemisinins | 1 | 2020 | 216 | 0.160 |
Why?
|
Molecular Epidemiology | 2 | 2022 | 451 | 0.150 |
Why?
|
Transition Temperature | 1 | 2017 | 35 | 0.150 |
Why?
|
Anopheles | 1 | 2018 | 187 | 0.130 |
Why?
|
Models, Genetic | 2 | 2017 | 3425 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2017 | 607 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 744 | 0.120 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 231 | 0.120 |
Why?
|
Antibodies, Protozoan | 1 | 2014 | 246 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1075 | 0.110 |
Why?
|
Antigens, Protozoan | 1 | 2014 | 312 | 0.100 |
Why?
|
Program Evaluation | 1 | 2020 | 2455 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 780 | 0.090 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 134 | 0.090 |
Why?
|
Sri Lanka | 2 | 2020 | 88 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2113 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1521 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1177 | 0.080 |
Why?
|
Child | 7 | 2022 | 78517 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3616 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3068 | 0.070 |
Why?
|
Child, Preschool | 6 | 2022 | 41406 | 0.070 |
Why?
|
Cluster Analysis | 3 | 2022 | 2673 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14546 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1417 | 0.060 |
Why?
|
Prevalence | 3 | 2017 | 15308 | 0.060 |
Why?
|
Population Surveillance | 1 | 2015 | 2587 | 0.060 |
Why?
|
Research | 1 | 2011 | 1954 | 0.050 |
Why?
|
Computational Biology | 1 | 2015 | 3489 | 0.050 |
Why?
|
Humans | 20 | 2022 | 746897 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20822 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2556 | 0.050 |
Why?
|
Adolescent | 6 | 2022 | 86323 | 0.050 |
Why?
|
Sulfadoxine | 1 | 2020 | 46 | 0.050 |
Why?
|
Models, Statistical | 1 | 2015 | 5038 | 0.040 |
Why?
|
Infant | 3 | 2018 | 35465 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2021 | 115 | 0.040 |
Why?
|
Gambia | 1 | 2018 | 102 | 0.040 |
Why?
|
Burkina Faso | 1 | 2018 | 85 | 0.040 |
Why?
|
Young Adult | 4 | 2018 | 57221 | 0.040 |
Why?
|
Primaquine | 1 | 2017 | 28 | 0.040 |
Why?
|
Genetic Markers | 2 | 2015 | 2595 | 0.040 |
Why?
|
Liberia | 1 | 2017 | 168 | 0.040 |
Why?
|
Population Dynamics | 1 | 2018 | 300 | 0.030 |
Why?
|
Comoros | 1 | 2015 | 11 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2017 | 757 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 2018 | 297 | 0.030 |
Why?
|
Nigeria | 1 | 2018 | 753 | 0.030 |
Why?
|
Parasitology | 1 | 2015 | 28 | 0.030 |
Why?
|
Chloroquine | 1 | 2017 | 277 | 0.030 |
Why?
|
Family Characteristics | 1 | 2020 | 978 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.030 |
Why?
|
South America | 1 | 2015 | 182 | 0.030 |
Why?
|
Base Sequence | 2 | 2015 | 12467 | 0.030 |
Why?
|
Animals | 5 | 2022 | 166593 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 958 | 0.030 |
Why?
|
Asia | 1 | 2015 | 602 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2608 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 458 | 0.030 |
Why?
|
Africa | 1 | 2015 | 690 | 0.030 |
Why?
|
Tanzania | 1 | 2017 | 1360 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1880 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57627 | 0.020 |
Why?
|
Molecular Typing | 1 | 2012 | 110 | 0.020 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
Male | 6 | 2022 | 351556 | 0.020 |
Why?
|
Travel | 1 | 2017 | 782 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.020 |
Why?
|
Insect Vectors | 1 | 2011 | 133 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 296 | 0.020 |
Why?
|
Ethanolamines | 1 | 2011 | 156 | 0.020 |
Why?
|
Adult | 4 | 2018 | 215291 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6465 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 159 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2688 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6841 | 0.020 |
Why?
|
Blood | 1 | 2012 | 583 | 0.020 |
Why?
|
Fever | 1 | 2017 | 1604 | 0.020 |
Why?
|
Female | 5 | 2022 | 382617 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3534 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6072 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13514 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4620 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1223 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2011 | 880 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1963 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 556 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9522 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2722 | 0.020 |
Why?
|
Aged | 1 | 2017 | 164472 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4480 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17701 | 0.010 |
Why?
|
Middle Aged | 1 | 2017 | 214711 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14126 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2679 | 0.010 |
Why?
|
Software | 1 | 2015 | 4401 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25197 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40540 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7596 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6066 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19827 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 29643 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_